Vestal Point Capital’s Abbott ABT Stock Holding History

Vestal Point Capital’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-600,000	Closed	-$75.2M	–	91
2025 Q4	$75.2M	Buy	600,000 +350,000	+140%	+$44.6M	2.56%	12
2025 Q3	$33.5M	Buy	250,000 +75,000	+43%	+$9.85M	1.51%	25
2025 Q2	$23.8M	Buy	+175,000	New	+$23.1M	1.25%	31

Other funds holding ABT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vestal Point Capital's ABT Position: Q1 2026 in Review

Vestal Point Capital sold out of Abbott (ABT) in Q1 2026, closing a stake of 600,000 shares — an estimated $75.2M sold.

Vestal Point Capital first reported a position in ABT in Q2 2025 and held it in 3 quarters. The position peaked at $75.2M in Q4 2025. 3,089 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

Vestal Point Capital reported no remaining Abbott position as of Q1 2026 after selling out during the quarter.
Vestal Point Capital sold 600,000 Abbott shares in Q1 2026, an estimated $75.2M.
Vestal Point Capital first reported a position in Abbott in Q2 2025 and held it in 3 quarters.
Vestal Point Capital's Abbott position peaked at $75.2M in Q4 2025.
3,089 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Vestal Point Capital's 13F filing for Q1 2026, filed 15 May 2026.